NCT06520553View on ClinicalTrials.gov

A Study in Healthy Men to Test How BI 1569912 is Processed in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 26, 2024

Primary Completion Date

October 3, 2024

Study Completion Date

October 3, 2024

Conditions
Healthy
Interventions
DRUG

BI 1569912 (C-14)

unlabelled BI 1569912 mixed with \[14C\]- labelled BI 1569912

DRUG

BI 1569912 (C-13)

\[13C\]- labelled BI 1569912

Trial Locations (1)

9728 NZ

ICON-Groningen-62040, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06520553 - A Study in Healthy Men to Test How BI 1569912 is Processed in the Body | Biotech Hunter | Biotech Hunter